Wells Fargo
IDXX icon

Wells Fargo’s Idexx Laboratories IDXX Stock Holding History

Wells Fargo’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100
Closed -$66K – 7394
2021
Q4 		$66K Buy
+100
New +$62.8K ﹤0.01% 5839

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo's IDXX Position: Q1 2026 in Review

Wells Fargo increased its Idexx Laboratories (IDXX) stake by 1.6% in Q1 2026, buying an estimated $2.15M and bringing the position to 208,847 shares worth $117M. The position accounts for 0.02% of the portfolio, ranked #571.

Wells Fargo first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $140M in Q2 2021. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Wells Fargo held 208,847 shares of Idexx Laboratories worth $117M as of Q1 2026.
  • Wells Fargo bought 3,360 Idexx Laboratories shares in Q1 2026, an estimated $2.15M.
  • Idexx Laboratories made up 0.02% of Wells Fargo's portfolio in Q1 2026, its #571 holding.
  • Wells Fargo first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Idexx Laboratories position peaked at $140M in Q2 2021.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.